检索结果 - Gorjan Hrustanovic
- Showing 1 - 4 results of 4
-
1
-
2
NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer 由 Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas, Saurabh Asthana, Jenny Yan, Irena Tan, Gorjan Hrustanovic, Elton Chan, Luping Lin, Dana S. Neel, W. H. Newton, Kathryn Bobb, Timothy Fouts, Jeffrey Meshulam, Matthew A. Gubens, David M. Jablons, Jeffrey R. Johnson, Sourav Bandyopadhyay, Nevan J. Krogan, Trever G. Bivona
出版 2015Artigo -
3
Inactivation of Capicua drives cancer metastasis 由 Ross A. Okimoto, Frank Breitenbuecher, Victor Olivas, Wei Wu, Beatrice Gini, Matan Hofree, Saurabh Asthana, Gorjan Hrustanovic, Jennifer C. Flanagan, Asmin Tulpule, Collin M. Blakely, Henry J. Haringsma, Andrew D. Simmons, Kyle Gowen, James Suh, Vincent A. Miller, Siraj M. Ali, Martin Schüler, Trever G. Bivona
出版 2016Artigo -
4
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer 由 Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana, Collin M. Blakely, Ross A. Okimoto, Luping Lin, Dana S. Neel, Amit J. Sabnis, Jennifer C. Flanagan, Elton Chan, Marileila Varella‐Garcia, Dara L. Aisner, Aria Vaishnavi, Sai‐Hong Ignatius Ou, Eric A. Collisson, Eiki Ichihara, Philip C. Mack, Christine M. Lovly, Niki Karachaliou, Rafael Rosell, Jonathan W. Riess, Robert C. Doebele, Trever G. Bivona
出版 2015Artigo
相关主题
Cancer
Cancer research
Lung cancer
Medicine
Oncology
Biology
Internal medicine
Adenocarcinoma
EGFR inhibitors
Epidermal growth factor receptor
Genetics
Immunology
ALK inhibitor
Acquired resistance
Anaplastic lymphoma kinase
Biomarker
Cell cycle
Colorectal cancer
Crizotinib
Downregulation and upregulation
Effector
Erlotinib
Gefitinib
Gene
Inflammation
KRAS
Kinase
Leukemia
MAPK/ERK pathway
Malignant pleural effusion